W Woloszczuk

Author PubWeight™ 74.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of clodronate treatment on bone scintigraphy in metastatic breast cancer. J Nucl Med 1993 2.20
2 Serum sclerostin levels decline in post-menopausal women with osteoporosis following treatment with intermittent parathyroid hormone. J Endocrinol Invest 2012 1.43
3 Plasma atrial natriuretic factor in cirrhotic patients with ascites. Effect of peritoneovenous shunt implantation. Gastroenterology 1988 1.39
4 Big-endothelin release in baboon bacteremia is partially TNF dependent. J Lab Clin Med 1994 1.39
5 Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide. Osteoporos Int 2011 1.23
6 Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications. Diabetologia 1988 1.23
7 Serum levels of osteoprotegerin increase with age in a healthy adult population. Bone 2003 1.23
8 Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages. Transplantation 1990 1.18
9 Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci 1989 1.11
10 Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis. Rheumatol Int 2005 1.11
11 Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 1993 1.11
12 Assessment of vitamin D and calcium status in healthy adult Austrians. Eur J Clin Invest 2003 1.06
13 Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure. Eur Heart J 2002 1.05
14 Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans. Diabetologia 1991 1.03
15 A sensitive immunoradiometric assay for gamma interferon, suitable for its measurement in serum. Clin Chem 1985 1.01
16 Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clin Exp Immunol 1992 0.98
17 Catalase biosynthesis in yeast: formation of catalase A and catalase T during oxygen adaptation of Saccharomyces cerevisiae. Eur J Biochem 1976 0.96
18 Normative data of bone mineral density in an unselected adult Austrian population. Eur J Clin Invest 2003 0.94
19 Bone mass and biochemical parameters of bone metabolism in men with spinal osteoporosis. Eur J Clin Invest 1992 0.91
20 Decreased serum osteocalcin levels in phenprocoumon-treated patients. J Clin Endocrinol Metab 1988 0.91
21 Cardiac calcific deposits in patients with primary hyperparathyroidism: preliminary results of a prospective echocardiographic study. Surgery 1990 0.90
22 Radioimmunoassay of endothelin. Lancet 1989 0.89
23 [Initial experiences with substitution treatment of hypoparathyroidism with synthetic human parathyroid hormone]. Monatsschr Kinderheilkd 1990 0.89
24 Increased serum osteocalcin levels in patients with paraplegia. Paraplegia 1992 0.89
25 Peripheral insulin resistance in primary hyperparathyroidism. Metabolism 1983 0.88
26 Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure. J Am Coll Cardiol 1998 0.88
27 Successful parathyroidectomy in primary hyperparathyroidism: a clinical follow-up study of 212 consecutive patients. Surgery 1987 0.86
28 Purification and characterization of a pig intestinal alpha-limit dextrinase. Eur J Biochem 1983 0.86
29 Primary hyperparathyroidism and the heart: cardiac abnormalities correlated to clinical and biochemical data. World J Surg 1995 0.85
30 The relation of heme to catalase apoprotein synthesis in yeast. J Biol Chem 1980 0.85
31 Relationship between neopterin and granulocyte elastase plasma levels and the severity of multiple organ failure. Crit Care Med 1989 0.85
32 Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus. Ann Rheum Dis 2000 0.84
33 Human atrial natriuretic peptide secretion in precapillary pulmonary hypertension. Clinical study in patients with COPD and interstitial fibrosis. Chest 1988 0.84
34 Autocrine cell suicide in a Burkitt lymphoma cell line (Daudi) induced by interferon alpha: involvement of tumor necrosis factor as ligand for the CD95 receptor. Blood 2001 0.83
35 Tubulointerstitial nephritis and uveitis: an immunological disorder? Pediatr Nephrol 1995 0.83
36 Atrial natriuretic peptide concentrations in blood from right atrium in patient with severe right heart failure. Lancet 1985 0.83
37 Relationship of interferon-gamma and neopterin levels during stimulation with alloantigens in vivo and in vitro. Transplantation 1986 0.83
38 Bone turnover markers and sex hormones in men with idiopathic osteoporosis. Eur J Clin Invest 2001 0.83
39 Radioimmunoassay of immunoreactive C-terminal big-endothelin(22-38). Eur J Clin Chem Clin Biochem 1991 0.82
40 Secondary hyperparathyroidism and acute tubular necrosis following renal transplantation. Nephrol Dial Transplant 1993 0.82
41 Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases. Kidney Int 2001 0.81
42 Living on chronic hemodialysis between dryness and fluid overload. Kidney Int Suppl 1997 0.81
43 Influence of sex and age on biochemical bone metabolism parameters. Miner Electrolyte Metab 1994 0.80
44 Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables. J Heart Lung Transplant 1998 0.80
45 Decreased serum osteocalcin levels in patients with postmenopausal osteoporosis. Acta Med Austriaca 1991 0.80
46 Morphologic and functional studies to prevent graft-dependent recurrence in renal osteodystrophy. Surgery 1989 0.80
47 [Hyperparathyroidism in chronic renal insufficiency new clinical and surgical aspects (author's transl)]. Wien Klin Wochenschr 1981 0.79
48 Serum osteocalcin levels in breast cancer patients. J Cancer Res Clin Oncol 1989 0.79
49 Mechanical ventilation with positive end-expiratory pressure decreases release of alpha-atrial natriuretic peptide. Crit Care Med 1987 0.79
50 Calcitonin in pregnancy. Lancet 1980 0.79
51 Decreased serum osteocalcin levels in patients with liver cirrhosis. Bone Miner 1990 0.79
52 Increased serum osteocalcin levels in elderly females with vitamin D deficiency. Exp Clin Endocrinol 1990 0.79
53 Atrial natriuretic peptide decrease during spontaneous breathing with continuous positive airway pressure in volume-expanded healthy volunteers. Crit Care Med 1988 0.79
54 Pharmacokinetic cyclosporine A profiles under long-term Neoral treatment in renal transplant recipients: does fat intake still matter? Transplant Proc 1997 0.79
55 [Vitamin D deficiency rickets: single-dose therapy versus continuous therapy]. Padiatr Padol 1985 0.79
56 Sandwich ELISA for proANP 1-98 facilitates investigation of left ventricular dysfunction. Eur J Med Res 2001 0.79
57 Serum osteoprotegerin but not receptor activator of NF-kappaB ligand correlates with Larsen score in rheumatoid arthritis. Ann Rheum Dis 2004 0.79
58 Determination of parathyroid function after autotransplantation. Surgery 1981 0.78
59 Peripheral bone mineral content in patients with fatty liver and hepatic cirrhosis. Scand J Gastroenterol 1990 0.78
60 Serum levels of receptor activator of nuclear factor kappaB ligand (RANKL) in healthy women and men. Exp Clin Endocrinol Diabetes 2007 0.78
61 Bone mineral density and parameters of bone metabolism in patients with acromegaly. J Bone Miner Res 1993 0.78
62 Is pro-matrix metalloproteinase-3 a marker for posttraumatic cartilage degradation? Osteoarthritis Cartilage 2003 0.78
63 A circadian rhythm of serum osteocalcin levels in postmenopausal osteoporosis. Eur J Clin Invest 1990 0.78
64 [Phosphorus and calcium metabolism of premature infants fed human milk and formulated milk]. Padiatr Padol 1982 0.78
65 Parathyroid hormone does not inhibit platelet aggregation. Lancet 1984 0.78
66 Circadian variation and age dependence of human atrial natriuretic peptide levels in hospitalized patients. Horm Metab Res 1987 0.78
67 Radioimmunoassay of atrial natriuretic peptides in human plasma. Clin Chem 1986 0.77
68 Serum levels of cathepsin K decrease with age in both women and men. Exp Gerontol 2005 0.77
69 [Parathyroidectomy and autotransplantation in renal hyperparathyroidism. II. Morphologic and functional studies in transplant-dependent recurrence]. Chirurg 1989 0.77
70 N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment. Kidney Int 2000 0.77
71 Elevated circulating levels of beta 2-microglobulin in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 1993 0.77
72 Plasma atrial natriuretic peptide (ANP) fragments proANP (1-30) and proANP (31-67) measurements in chronic heart failure: a useful index for heart transplantation? Clin Chim Acta 2001 0.77
73 Clinical evaluation of new assays for determination of serum calcitonin concentrations. Acta Endocrinol (Copenh) 1991 0.77
74 Parathyroid hormone and calcium behavior in advanced congestive heart failure. Z Kardiol 1992 0.77
75 [Parathyroidectomy and autotransplantation in renal hyperparathyroidism. I. Morphologic studies for tissue selection]. Langenbecks Arch Chir 1988 0.77
76 Primary hyperparathyroidism in Austria: results of an 8-year prospective study. World J Surg 1992 0.76
77 Atrial natriuretic peptide release due to physical exercise in healthy persons and in cardiac patients. Klin Wochenschr 1987 0.76
78 Beta-2-microglobulin in hemodialysis patients. Effects of different dialyzers and different dialysis procedures. Am J Nephrol 1988 0.76
79 Effects of one-year hormone replacement therapy on peripheral bone mineral content in patients with osteoporotic spine fractures. Acta Endocrinol (Copenh) 1990 0.76
80 Calcitonin in pregnant women and in cord blood. Gynecol Obstet Invest 1981 0.76
81 [Cardiac changes in patients with hypercalcemia]. Wien Klin Wochenschr 1993 0.76
82 Receptor activator of nuclear factor kappaB ligand and osteoprotegerin in men with thyroid cancer. Eur J Clin Invest 2006 0.76
83 Serum osteocalcin levels in primary hyperparathyroidism. Klin Wochenschr 1991 0.76
84 [Parathyroidectomy and autotransplantation in renal hyperparathyroidism. I. Clinical and chemical laboratory studies following tissue selection]. Chirurg 1989 0.76
85 Pharmacokinetics and metabolism of cyclosporine A in 19 hemodialysis patients. Transplant Proc 1990 0.75
86 [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease]. Wien Klin Wochenschr 1985 0.75
87 Reduced islet-amyloid polypeptide in insulin-dependent diabetes mellitus. Lancet 1990 0.75
88 Immunosuppressive properties of cyclosporin metabolites. Lancet 1989 0.75
89 Serum osteocalcin levels are decreased in patients with acute viral hepatitis. Bone Miner 1991 0.75
90 Effect of L-thyroxine on bone mass. Ann Intern Med 1991 0.75
91 Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency. Calcif Tissue Int 1998 0.75
92 [Human atrial natriuretic factor (hANF) in liver cirrhosis]. Acta Med Austriaca 1987 0.75
93 [Disodium pamidronate (APD) in therapy of hypercalcemia in primary hyperparathyroidism]. Wien Klin Wochenschr 1994 0.75
94 [Serum osteocalcin (BGP) as a "marker" of bone mineral content in postmenopausal women]. Gynakol Rundsch 1989 0.75
95 Neopterin and interferon gamma serum levels in patients with heart and kidney transplants. J Clin Chem Clin Biochem 1986 0.75
96 Immobilization of alpha-human atrial natriuretic peptide on insoluble supports and affinity purification of specific antibodies from a polyclonal goat anti-alpha-human atrial natriuretic peptide serum. J Chromatogr 1990 0.75
97 [Value of calcitonin and 6-oxo-prostaglandin Fl alpha in the differentiation of lung cancers]. Acta Med Austriaca 1987 0.75
98 Statistical and computer evaluation of the cytologic monitoring of kidney graft recipients in the immediate posttransplantation period. Transplant Proc 1988 0.75
99 Plasma levels of granulocyte elastase and neopterin in patients with MOF. Prog Clin Biol Res 1989 0.75
100 [Epidemiological research on primary hyperparathyroidism. A prospective multicenter study]. Dtsch Med Wochenschr 1988 0.75
101 Enzyme immunoassays for fragments (epitopes) of human proatrial natriuretic peptides. Clin Chem Lab Med 2000 0.75
102 Neopterin and interferon gamma serum levels in renal allograft recipients. Child Nephrol Urol 1989 0.75
103 Urinary and plasma urodilatin measured by a direct RIA using a highly specific antiserum. Clin Chem 1998 0.75
104 Biocompatibility of high-flux membranes. Int J Artif Organs 1992 0.75
105 Effect of elevated serum prolactin concentrations on cytokine production and natural killer cell activity. Neuroendocrinology 1992 0.75
106 [Atrial natriuretic peptide (ANP) in cardiologic laboratory diagnosis]. Z Med Lab Diagn 1989 0.75
107 Effect of infusion of salmon calcitonin on the secretion of somatostatin and gastrin in man. Horm Metab Res 1986 0.75
108 Calcitonin- and katacalcin-like immunoreactivity in human seminal plasma. Exp Clin Endocrinol 1986 0.75
109 Plasma levels of atrial natriuretic peptide (ANP) in volume expanded patients: response to fluid removal by continuous pump driven hemofiltration. Klin Wochenschr 1986 0.75
110 Interpretation of plasma concentrations of human atrial natriuretic peptide (hANP) in congestive heart failure. Acta Med Austriaca 1990 0.75
111 High total and free 1,25-dihydroxyvitamin D concentrations in serum of premature infants. Acta Paediatr Scand 1990 0.75
112 N-terminal fragments of the proatrial natriuretic peptide in plasma and urine of kidney graft recipients. Transplantation 2001 0.75
113 [Hypercalcemia and primary hyperparathyroidism. Epidemiologic and diagnostic aspects]. Acta Med Austriaca 1982 0.75
114 How to measure cyclosporin. Lancet 1984 0.75
115 [Determination of parathyroid hormones and calcitonin]. Med Lab (Stuttg) 1982 0.75
116 Radioimmunoassay and plasma levels of endothelin, a vasoconstrictor of potential importance in renal disease. Contrib Nephrol 1990 0.75
117 Studies on the biosynthesis of cyclitols, XXXI. Further investigations on the biosynthesis of laminitol (1D-4-c-methyl-myo-inositol) in Porphyridium sp. Hoppe Seylers Z Physiol Chem 1974 0.75
118 Estimation of ciclosporin levels using a ciclophilin-binding assay. Bibl Cardiol 1988 0.75
119 Neoral--a new microemulsion formula of cyclosporine A: interpatient pharmacokinetic variability in renal transplant recipients. Transplant Proc 1995 0.75
120 Continuous pump-driven hemofiltration associated with a decline in alpha-atrial natriuretic peptide. Crit Care Med 1986 0.75
121 Medullary thyroid carcinomas express chromogranin A and a novel neuroendocrine protein recognized by monoclonal antibody HISL-19. Am J Med 1988 0.75
122 [Human calcitonin in the treatment of symptomatic Paget's disease]. Aktuelle Gerontol 1983 0.75
123 Effect of calcium loading test on calcitonin and katacalcin levels before and after surgical removal of the ovaries. Exp Clin Endocrinol 1985 0.75
124 Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients. Chest 2000 0.75
125 Heterogeneity of immunoreactive calcitonin in extracts of normal human thyroid. Horm Metab Res 1981 0.75
126 Calcitonin in healthy children. Horm Metab Res 1981 0.75
127 [Antiepileptic-induced osteomalacia and vitamin D therapy]. Nervenarzt 1983 0.75
128 Radioimmunological determination of arginine vasopressin and human atrial natriuretic peptide after simultaneous extraction from plasma. J Clin Chem Clin Biochem 1986 0.75
129 The role of alpha-atrial natriuretic peptide in fluid retention during mechanical ventilation with positive end-expiratory pressure. Klin Wochenschr 1986 0.75
130 A purification of Helix pomatia alpha amylase involving a novel affinity-binding procedure. Carbohydr Res 1978 0.75
131 Circulating immunoreactive proANP(1-30) and proANP(31-67) in sedentary subjects and athletes. Clin Chem 2000 0.75
132 Single-dose response kinetics of oral cyclosporine A: a critical reexamination. Transplant Proc 1992 0.75
133 Cimetidine in secondary hyperparathyroidism. Ann Intern Med 1982 0.75
134 Determination of alpha-human atrial natriuretic peptide (alpha-hANP) in urine using combination HPLC with RIA strongly indicates non-immunoreactive metabolites. J Biochem Biophys Methods 1990 0.75
135 [Methodological problems in the radioimmunologic measurement of ANP (atrial natriuretic peptide)]. Z Kardiol 1988 0.75
136 Iron removal by desferrioxamine in patients on chronic hemodialysis--kinetic study and long-term results. Contrib Nephrol 1985 0.75
137 Evidence for negative correlation between quantitative histological studies and microradiography of iliac crest bone and forearm osteodensitometry in elderly women with osteoporosis. Calcif Tissue Int 1982 0.75
138 [The significance of the 5th gland as a cause of primary hyperparathyroidism. Case report and review of the literature]. Chirurg 1983 0.75
139 Bone metabolism in patients with functioning kidney grafts: increased serum levels of osteocalcin and parathyroid hormone despite normalisation of kidney function. Nephron 1991 0.75
140 [Phosphate depletion syndrome in prematures fed human milk]. Klin Padiatr 1983 0.75
141 Plasma alkaline phosphatase activity in preterm neonates. Lancet 1982 0.75
142 Response of right ventricular function to prostaglandin E1 infusion predicts outcome for severe chronic heart failure patients awaiting urgent transplantation. J Heart Lung Transplant 2000 0.75
143 Determination of cyclosporine by a competitive binding assay with cyclophilin. Clin Chem 1991 0.75
144 Plasma levels of elastase 1 protease inhibitor complex in the monitoring of ARDS and multi-organ failure--a summary of three clinical trials. Adv Exp Med Biol 1988 0.75
145 Determination of vitamin D binding protein by Scatchard analysis and estimation of a free 25-hydroxy-vitamin D index. Clin Chim Acta 1985 0.75
146 [Peripheral and right atrial plasma levels of atrial natriuretic peptide and their relation to mean atrial pressure]. Z Kardiol 1987 0.75
147 [Principles and value of biochemical methods of analysis]. Padiatr Padol 1983 0.75
148 Multiple myeloma and primary hyperparathyroidism. Blut 1985 0.75
149 Thyroid hormones and pericardial effusion may influence plasma levels of atrial natriuretic peptide (ANP) in humans. Klin Wochenschr 1986 0.75
150 Determination of circulating monomeric katacalcin and calcitonin: physiological studies in normal subjects. J Clin Chem Clin Biochem 1986 0.75
151 Interferon-gamma, neopterin, and interleukin-2 receptor levels in the serum of kidney transplant recipients. Transplant Proc 1990 0.75
152 [Sipple syndrome (bilateral phaeochromocytoma medullary C-cell carcinoma of the thyroid gland) with exceptionally prolonged clinical course]. Wien Klin Wochenschr 1982 0.75
153 Adsorption of natriuretic factors in uremia. Semin Nephrol 2001 0.75
154 [Muscle cell proteins are selectively released into the blood stream by marathon running]. Acta Med Austriaca 2003 0.75
155 Calcitonin temporarily increases 6-oxo-prostaglandin F1 alpha-levels in man. Prostaglandins 1980 0.75
156 Iodogen-catalysed iodination of human calcitonin and Tyr(0)-katacalcin and purification of their mono- and di-iodinated derivatives by chromatofocussing. J Immunol Methods 1986 0.75